Boston Scientific

Boston Scientific Corporation
TypePublic
IndustryMedical device
Founded1979
FoundersJohn Abele, Founder & Director Emeritus
Peter Nicholas, Founder & Director Emeritus
HeadquartersMarlborough, Massachusetts, United States
Key people
Michael F. Mahoney, Chairman and (CEO)
Daniel Brennan, CFO
RevenueIncrease $10.74 billion (2019)[1]
Increase $1.51 billion (2019)[1]
Increase $4.70 billion (2019)[1]
Total assetsIncrease $30.57 billion (2019)[1]
Total equityIncrease $13.88 billion (2019)[1]
Number of employees
36,000[2] (2019)
Websitebostonscientific.com

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Boston Scientific is primarily known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries.[3] With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD).[4][5]

  1. ^ a b c d e https://news.bostonscientific.com/2020-02-05-Boston-Scientific-Announces-Results-For-Fourth-Quarter-And-Full-Year-2019
  2. ^ http://investors.bostonscientific.com/~/media/Files/B/Boston-Scientific-IR/annual-reports-proxy-statements/2019_boston-scientific_performance_report.pdf
  3. ^ Shelley Wood (4 Mar 2004). "FDA approves Taxus paclitaxel-eluting stent". www.medscape.com/. Retrieved 20 Feb 2015.
  4. ^ "Boston Scientific Closes Cameron Health Acquisition". PR Newswire. UBM PLC. 8 June 2012. Retrieved 26 February 2016.
  5. ^ "EMBLEM S-ICD System". Boston Scientific. Archived from the original on 26 February 2016. Retrieved 26 February 2016.